James Kuo
Gründer bei TRYPTAMINE THERAPEUTICS LIMITED
Vermögen: 312 447 $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Eric Weisblum | M | 54 | 14 Jahre | |
Joshua Schafer | M | 53 | 4 Jahre | |
Christopher Schaber | M | 57 | 18 Jahre | |
James Gilligan | M | 72 | 4 Jahre | |
Peter Molloy | M | 52 | 4 Jahre | |
Jennifer Bath | M | - | 6 Jahre | |
Philip Jull | M | 64 | 4 Jahre | |
Hugo Brugière | M | - | 2 Jahre | |
Jeff Pavell | M | 57 | 2 Jahre | |
Kevin Muñoz | M | 46 | 4 Jahre | |
Wayne Linsley | M | 67 | 4 Jahre | |
Gregg Lapointe | M | 65 | 15 Jahre | |
Xavier Paoli | M | - | 10 Jahre | |
Thomas W. Gosney | M | - |
OncoTracker, Inc.
OncoTracker, Inc. Pharmaceuticals: MajorHealth Technology OncoTracker, Inc. is a medical diagnostics company focusing on immuno-oncology. The firm involves research and drug discovery in hematological cancers. It provides therapies, sBCMA testing, and testing and services. The company was founded by James R Berenson in 2014 and is headquartered in West Hollywood, CA. | 5 Jahre |
Lawrence Steinman | M | 76 | 4 Jahre | |
Robert Rubin | M | 78 | 15 Jahre | |
Sidney Taubenfeld | M | - | 2 Jahre | |
Serguei Nabirotchkine | M | - | 17 Jahre | |
Joseph de Angelo | M | - |
ApoLife, Inc.
ApoLife, Inc. Miscellaneous Commercial ServicesCommercial Services ApoLife, Inc. provides screening and lab services. James S. Kuo has been the CEO of the American company since 2012. | - |
Raj Thota | M | - | 3 Jahre | |
Josh Lawler | M | - |
Return Health, Inc.
Return Health, Inc. BiotechnologyHealth Technology Return Health, Inc. develops and manufactures psychedelic medicines for dementia. The CEO of the American company is James S. Kuo. | - |
James O’Neill | M | 64 | 2 Jahre | |
Abhijit Pangu | M | - | 3 Jahre | |
Dirk Witters | M | - | 1 Jahre | |
Geraldine Kuo | F | - |
Athena Bioventures, Inc
Athena Bioventures, Inc Financial ConglomeratesFinance Athena Bioventures, Inc provides investment services. The private company is based in La Jolla, CA. The CEO of the company is Geraldine Kuo. | - |
Peter Guzzo | M | - | 4 Jahre | |
Antoine Gravelle | M | - | 2 Jahre | |
Melissa Israel | F | - | 4 Jahre | |
Barry Springer | M | - | 1 Jahre | |
Kristin Taylor | F | - | 1 Jahre | |
Anthony Ruizcalderon | M | - |
Return Health, Inc.
Return Health, Inc. BiotechnologyHealth Technology Return Health, Inc. develops and manufactures psychedelic medicines for dementia. The CEO of the American company is James S. Kuo. | - |
Payal Sahni Becher | F | - | 27 Jahre | |
Ilse Roodink | M | - | 3 Jahre | |
Joy K. Saha | M | - |
Athena Bioventures, Inc
Athena Bioventures, Inc Financial ConglomeratesFinance Athena Bioventures, Inc provides investment services. The private company is based in La Jolla, CA. The CEO of the company is Geraldine Kuo. | - |
Andrew Saich | M | - |
Return Health, Inc.
Return Health, Inc. BiotechnologyHealth Technology Return Health, Inc. develops and manufactures psychedelic medicines for dementia. The CEO of the American company is James S. Kuo. | - |
Henri Sant-Cassia | M | 47 |
Return Health, Inc.
Return Health, Inc. BiotechnologyHealth Technology Return Health, Inc. develops and manufactures psychedelic medicines for dementia. The CEO of the American company is James S. Kuo. | - |
Chris Buyse | M | 59 | 1 Jahre | |
Philippe Rinaudo | M | - | 9 Jahre | |
Guy-Charles Fanneau de la Horie | M | 64 | 1 Jahre | |
Susanne Dorn | F | - | 6 Jahre | |
Michael Silverman | M | - | - | |
Richard Gareth Skaife | M | - |
Return Health, Inc.
Return Health, Inc. BiotechnologyHealth Technology Return Health, Inc. develops and manufactures psychedelic medicines for dementia. The CEO of the American company is James S. Kuo. | - |
Adam T. Rumage | M | - | 17 Jahre | |
Gilbert Wagener | M | - | 1 Jahre | |
Daniel Ryweck | M | 59 | 2 Jahre | |
Christopher Ntoumenopoulos | M | - | 2 Jahre | |
Jason Carroll | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jeffrey Riley | M | 61 | 7 Jahre | |
Robert Beecroft | M | - | 31 Jahre | |
Thomas D'Orazio | M | - | 1 Jahre | |
Shepard M. Goldberg | M | 69 |
Cordex Pharma, Inc.
Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | - |
Christopher P. Schnittker | M | 55 | - | |
Liisa Irmeli Laitinen | F | 69 | 18 Jahre | |
Garner William | M | 58 | 3 Jahre | |
Dave Tousley | M | 69 | 1 Jahre | |
Kris M. Maly | F | - | - | |
Nelson K. Stacks | M | 53 | - | |
A. Joseph Rudick | M | 67 | 3 Jahre | |
Josie Taylor | F | - | - | |
Julie A. Caudill | F | - | - | |
George J. Brewer | M | - | - | |
Joseph M. Danis | M | - | 10 Jahre | |
Gianpaolo Andreola | M | 60 | 3 Jahre | |
Lisa Helbling | F | - | 4 Jahre | |
Robert Burke | M | - | 6 Jahre | |
Brad McConn | M | - | 1 Jahre | |
David Solomon | M | 63 | 2 Jahre | |
Martin MacKay | M | 68 | 14 Jahre | |
Gregory M. McKee | M | 60 | 1 Jahre | |
Charles Bisgaier | M | 71 | 2 Jahre | |
Piers John Morgan | M | 57 | 1 Jahre | |
Michael Brown | M | 83 | 16 Jahre | |
Gregory Smith | M | 57 | 7 Jahre | |
Scott Tarriff | M | 64 | 8 Jahre | |
Lyman Max Lyon | M | - | 1 Jahre | |
Alan Tuchman | M | 77 |
Cordex Pharma, Inc.
Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | - |
Michel de Rosen | M | 73 | 8 Jahre | |
Mary Winston | F | 62 | 7 Jahre | |
Alexandra Pearce | M | - | 11 Jahre | |
Martin Mattingly | M | 66 | 7 Jahre | |
Natasha Kehimkar | F | - | 16 Jahre | |
Roger Leone | M | - | 14 Jahre | |
Roxanne Lagano | F | 59 | - | |
Shankar Musunuri | M | 60 | 14 Jahre | |
Dilip J. Mehta | M | 91 | 15 Jahre | |
David L. Brinkley | M | 66 | - | |
Thomas G. Gant | M | - | 6 Jahre | |
Ruth Simmons | M | 78 | 10 Jahre | |
Michael Berelowitz | M | 79 | 15 Jahre | |
Pedro Lichtinger | M | 70 | 14 Jahre | |
Liam Ratcliffe | M | 60 | 12 Jahre | |
Franklin Raines | M | 74 | 3 Jahre | |
Sep Sarshar | M | 57 | 3 Jahre | |
Michael T. Sweeney | M | 63 | 8 Jahre | |
Kevin Koch | M | 63 | 7 Jahre | |
Christopher S. Hassan | M | 63 | 4 Jahre | |
Gerard G. Gorman | M | 73 | 5 Jahre | |
Jonathan Treherne | M | 63 | - | |
David F. Fitzgerald | M | 90 | 26 Jahre | |
Nazanine Scheuer | F | - | 9 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 58 | 58,00% |
Kanada | 25 | 25,00% |
Frankreich | 16 | 16,00% |
Finnland | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen